Promising research offers hope in the fight against resistant bacteria

Gender-affirming healthcare shouldn’t be limited to adults, members of the American Medical Association (AMA) House of Delegates said Monday at the delegates’ interim meeting in

Im­mutep’s pro­tein-based can­cer treat­ment has suc­ceed­ed in a mid-stage study in pa­tients with head and neck squa­mous cell car­ci­no­ma, spurring dis­cus­sions with reg­u­la­tors on a

Gener­ics pro­duc­er Glen­mark Phar­ma­ceu­ti­cals is di­vest­ing al­most com­plete­ly from its ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API)-man­u­fac­tur­ing sub­sidiary, sell­ing 75% of its shares to Nir­ma Lim­it­ed for $7.41